Omar Darwish

Mr. Omar Darwish


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2025 in Radiology: Imaging Cancer
Verified
Journal Article
Open access
ASAaditya P. Sinha
Aaditya P. Sinha
PJPatriek Jurrius
Patriek Jurrius
ASAnne-Sophie van Schelt
Anne-Sophie van Schelt
ODOmar Darwish
Omar Darwish
BSBelul Shifa
Belul Shifa
APArnie David Purushotham
Arnie David Purushotham
Assessment of tumor biomechanics through MR elastography improved the identification of complete responders among individuals with breast cancer undergoing neoadjuvant chemotherapy.

17 December 2024 in Sensors
Verified
Journal Article
Open access
PDF file
ODOmar Darwish
Omar Darwish
VKVitali Koch
Vitali Koch
Thomas Josef VoglThomas Josef Vogl
Thomas Josef Vogl
MWMarcos Wolf
Marcos Wolf
KSKatharina Schregel
Katharina Schregel
RSRalph Sinkus
Ralph Sinkus
MR elastography is a non-invasive imaging technique that provides quantitative maps of tissue biomechanical properties, i.e., elasticity and viscosity. Currently, hepatic MR elastography is deployed in the clinic to assess liver fibrosis in MAFLD patients. In addition, research has demonstrated MR elastography’s ability to non-invasively assess chronic liver disease and to characterize breast cancer lesions and brain tumors. MR elastography requires efficient mechanical wave generation and penetration, motion-sensitized MRI sequences, and MR elastography inversion algorithms to retrieve the biomechanical properties of the tissue. MR elastography promises to enable non-invasive and versatile assessment of tissue, leading to better diagnosis and staging of several clinical conditions.

25 November 2024 in Magnetic Resonance in Medicine
Verified
Journal Article
Open access
ODOmar Darwish
Omar Darwish
PCPierluigi Di Cio
Pierluigi Di Cio
RSRalph Sinkus
Ralph Sinkus
RNRadhouene Neji
Radhouene Neji
Purpose: To demonstrate the feasibility of hepatic 3D MR elastography (MRE) at 0.55 T in healthy volunteers using Hadamard encoding and to study the effects of concomitant fields in the domain of MRE in general. Methods: Concomitant field effects in MRE are assessed using a Taylor series expansion and an encoding scheme is proposed to study the corresponding effects on 3D MRE at 0.55 T in numerical simulations and in phantom experiments. In addition, five healthy volunteers were enrolled and scanned at 60 Hz mechanical excitation with a Hadamard‐encoded 3D MRE sequence at 0.55 T and were also scanned with a reference 3D MRE sequence at 3 T for comparison. The retrieved biomechanical parameters were the magnitude of the complex shear modulus (| G *|), the shear wave speed (Cs), and the loss modulus ( G ″). Comparison of apparent SNR between 3 T and 0.55 T was performed. Results: Theoretical analysis, numerical simulations and phantom experiments demonstrated that the effects of concomitant fields in 3D MRE at 0.55 T are negligible. In the healthy volunteer experiments, the mean values of | G *|, Cs, and G″ in the liver were 2.1 ± 0.3 kPa, 1.5 ± 0.1 m/s, and 0.8 ± 0.1 kPa at 0.55 T, respectively, and 2.0 ± 0.2 kPa, 1.5 ± 0.1 m/s, and 0.9 ± 0.1 kPa at 3 T, respectively. Bland–Altman analysis demonstrated good agreement between the biomechanical parameters retrieved at 0.55 T and 3 T. A 2.1‐fold relative apparent SNR decrease was observed in 3D MRE at 0.55 T in comparison with 3 T. Conclusion: Hepatic 3D MRE is feasible at 0.55 T, showing promising initial results in healthy volunteers.

16 July 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
AWAlexander Wollandt
Alexander Wollandt
LGLeon David Gruenewald
Leon David Gruenewald
CBChristian Booz
Christian Booz
JGJennifer Gotta
Jennifer Gotta
TBTeodora Biciusca
Teodora Biciusca
VKVitali Koch
Vitali Koch
Myocardial and aortic stiffness are increasingly recognized as clinically relevant biomarkers for cardiovascular disease, yet their noninvasive quantification remains challenging. Magnetic resonance elastography (MRE) has emerged as a promising technique for the spatial mapping of tissue biomechanics by visualizing and analyzing propagating shear waves. This narrative review summarizes the current state of cardiovascular MRE, spanning technical developments in wave generation (acoustic, electromagnetic, gravitational, and transducer-free approaches), pulse sequence design (echo-planar imaging, gradient-recalled echo, spiral, and free-breathing three-dimensional acquisitions), and inversion algorithms (local frequency estimation, direct inversion, finite element methods, and multifrequency elastography). We present evidence from phantom validation, animal models (myocardial infarction, hypertension, right ventricular hypertrophy), and human studies encompassing cardiac amyloidosis, hypertrophic cardiomyopathy, diastolic dysfunction, and abdominal aortic aneurysm. Additionally, we discuss current challenges, including waveguide effects, standardization needs, and clinical translation barriers, and highlight emerging solutions through artificial intelligence, multifrequency methods, and transducer-free cardiac MRE.

17 June 2026 in Annals of Medicine
Verified
Journal Article
Open access
ZLZhouyan Liao
Zhouyan Liao
SMSiyuan Ma
Siyuan Ma
ZLZiyi Liu
Ziyi Liu
HTHao Tang
Hao Tang
BDBaodi Deng
Baodi Deng
ZLZhen Li
Zhen Li
A critical dilemma in post-transplant surveillance is determining when minor functional changes (subtle serum creatinine fluctuations or slow renal function decline) or ambiguous ultrasound findings (including mildly elevated resistive index or cortical echogenicity) warrant invasive biopsy and treatment modification. We aimed to develop a non-invasive integrated tool combining advanced diffusion MRI with functional biomarkers to stratify patients within this diagnostic gray zone. In this prospective study, 120 renal transplant recipients underwent multi-b-value diffusion-weighted imaging at 3.0 T within 48 h prior to an allograft biopsy. Quantitative parameters of six diffusion MRI models were extracted from renal cortex and medulla. Clinical indicators, including serum HCO3-, were recorded. To establish a clear endpoint, patients were categorized into a Treatment-Changed group (presence of actionable active pathology, requiring modified therapies) and a Treatment-Unchanged group (normal or solely chronic/non-reversible lesions). Multivariable logistic regression identified independent predictors. Diagnostic performance was assessed using area under the curve (AUC) using repeated stratified 5-fold cross validation with 10 repeats and bootstrap resampling. Kaplan–Meier analysis assessed the association between model-based risk and subsequent graft functional decline, defined as a 30% or greater decrease in estimated glomerular filtration rate (eGFR) from baseline. The cortical distributed diffusion coefficient (DDC) and serum HCO3-, emerged as independent predictors of treatment-changed group. The integrated model achieved an AUC of 0.941, significantly outperforming the standard clinical reference model (eGFR, proteinuria, and ultrasound; AUC 0.563). Net reclassification improvement (0.479) demonstrated the model correctly reclassified 45.6% of patients. Furthermore, model-derived high-risk status significantly predicted long-term graft functional decline (log-rank p = 0.005). This integrated multiparametric protocol provides promising preliminary decision support for renal allograft surveillance. By noninvasively identifying the potential presence of actionable active pathology, this preliminary model may help optimize biopsy referrals and stratify patients who potentially require treatment modification. However, given the single-centre design, external validation is required before clinical implementation.

14 July 2026 in Magnetic Resonance in Medicine
Verified
Journal Article
Open access
YOYannik Ott
Yannik Ott
SMSarah McElroy
Sarah McElroy
RTRaphael Tomi‐Tricot
Raphael Tomi‐Tricot
CHCarolyn Horst
Carolyn Horst
PGPatricia A. Gutierrez
Patricia A. Gutierrez
RNRadhouene Neji
Radhouene Neji
Purpose: To develop a 3D reduced FOV sequence for combined ADC and T 2 mapping in the prostate in a single scan. Methods: A 3D ADC and T 2 mapping reduced FOV acquisition is enabled using T 2 and diffusion preparation modules with slab‐selective tip‐down pulses and magnitude stabilizer gradients. Imaging shots are followed by 2D phase navigators for phase correction of diffusion‐prepared shots and dummy RF pulses for T 2 ‐prepared shots, as well as a constant delay to maintain the steady state of the longitudinal magnetization. Mono‐exponential fitting is used for ADC and T 2 mapping. T 2 mapping accuracy was assessed in a phantom against a single‐echo spin‐echo reference. In vivo, the sequence was compared in the prostate of 11 healthy volunteers against a multi‐echo spin‐echo acquisition, as well as standard and reduced FOV (rFOV) single‐shot EPI (ssEPI). Results: In the phantom experiments, T 2 values were not significantly different from the reference single‐echo spin‐echo measurements. ADC values in vivo were not significantly different from those obtained using ssEPI. T 2 values in vivo showed a mean bias of −21.7 ms compared to those obtained using multi‐echo spin‐echo with the first echo discarded in the fitting. The proposed sequence achieved similar overall image quality scores to those of ssEPI and rFOV ssEPI, improved perceived distortion scores, but lower perceived SNR scores. Conclusion: The proposed approach enables 3D reduced FOV, single‐scan ADC, and T 2 mapping with mono‐exponential fitting in the prostate.